Bell Investment Advisors, Inc Exelixis, Inc. Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 227 shares of EXEL stock, worth $8,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227
Previous 159
42.77%
Holding current value
$8,519
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EXEL
# of Institutions
564Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.1 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$880 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$574 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$428 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...